 |
|
|||||
|
||||||
        |
||||||
|
 |
|||||
|
|
|
|
|||
|
|
|||||
| Publications | ||||||
| Selected Scientific Publications Sundaram M, Qi Y, Shriver Z, Liu D, Zhao G,
Venkataraman G, Langer R, and Sasisekharan R. (2003) Rational design
of low molecular weight heparins with improved in vivo activity. Editorial Commentary (2002):Six blind men and the elephant - The many faces of heparan sulfate. Proc Natl Acad Sci U S A 99, 543-5. Liu D, Shriver Z, Venkataraman G, El Shabrawi Y, and Sasisekharan R. (2002) Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl. Acad. Sci. USA, 99, 568-73. Keiser N, Venkataraman G, Shriver Z, and Sasisekharan
R. (2001) Direct isolation and sequencing of specific protein-binding
glycosaminoglycans. Editorial Commentary (2000): Heparin Sequencing brings structure to the function of complex oligosaccharides, Proc. Natl. Acad. Sci. USA, 97, 10301-10303. Venkataraman, G, Shriver, Z, Raman, R, and
Sasisekharan, R. (1999) Sequencing complex polysaccharides. Shriver, Z., Raman, R., Venkataraman, G., Drummond, K., Turnbull, J., Toida., T., Linhardt, R., Biemann, K., & Sasisekharan, R (2000) Sequencing of 3-O Sulfate Containing Decasaccharides With a Partial Antithrombin III Binding Site, Proc. Natl. Acad. Sci. USA. 97(19):10359-10364. Sasisekharan R, Shriver Z, Venkataraman G, and Narayanaswamy U. (2002) Roles of heparan sulfate glycosaminoglycans in cancer. Nat. Rev. Cancer 2, 521-8. |
|
|||||
|
|
|
||||
|
|
|
|
|||
